IN8bio Statistics
Share Statistics
IN8bio has 90.77M
shares outstanding. The number of shares has increased by 84.16%
in one year.
| Shares Outstanding | 90.77M |
| Shares Change (YoY) | 84.16% |
| Shares Change (QoQ) | 12.11% |
| Owned by Institutions (%) | 63.46% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 19,243 |
| FTD / Avg. Volume | 1.42% |
Short Selling Information
The latest short interest is 426.33K, so 0.52% of the outstanding
shares have been sold short.
| Short Interest | 426.33K |
| Short % of Shares Out | 0.52% |
| Short % of Float | 0.63% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.45 and the forward
PE ratio is -0.68.
IN8bio's PEG ratio is
0.01.
| PE Ratio | -0.45 |
| Forward PE | -0.68 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 0.95 |
| P/FCF Ratio | -0.57 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for IN8bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.08,
with a Debt / Equity ratio of 0.35.
| Current Ratio | 4.08 |
| Quick Ratio | 4.08 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | -0.18 |
| Debt / FCF | -0.21 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,690,944.44 |
| Employee Count | 18 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -86.14% in the
last 52 weeks. The beta is 0.23, so IN8bio's
price volatility has been higher than the market average.
| Beta | 0.23 |
| 52-Week Price Change | -86.14% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 43.52 |
| Average Volume (20 Days) | 1,353,096 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -30.44M |
| Net Income | -30.44M |
| EBITDA | -27.78M |
| EBIT | -30.44M |
| Earnings Per Share (EPS) | -0.57 |
Full Income StatementBalance Sheet
The company has 11.12M in cash and 5.03M in
debt, giving a net cash position of 6.09M.
| Cash & Cash Equivalents | 11.12M |
| Total Debt | 5.03M |
| Net Cash | 6.09M |
| Retained Earnings | -121.66M |
| Total Assets | 19.87M |
| Working Capital | 9.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -24.15M
and capital expenditures -104K, giving a free cash flow of -24.25M.
| Operating Cash Flow | -24.15M |
| Capital Expenditures | -104K |
| Free Cash Flow | -24.25M |
| FCF Per Share | -0.45 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
